Snowden Capital Advisors’s GeneDx Holdings WGS Stock Holding History

Snowden Capital Advisors’s Portfolio WGS Stock Details WGS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-1	Closed	–	–	2054
2021 Q4	$0	Buy	+1	New	+$223	﹤0.01%	2167

Other funds holding WGS

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

SB Management Abu Dhabi, United Arab Emirates $516M AUM 40.71% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return

Third Point New York $2.08B AUM 27.04% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

DCMIC

Decheng Capital Management III (Cayman) Grand Cayman, Cayman Islands $300M AUM 15.74% 1-Year Est. Return

Snowden Capital Advisors's WGS Position: Q1 2022 in Review

Snowden Capital Advisors sold out of GeneDx Holdings (WGS) in Q1 2022, closing a stake of 1 share.

Snowden Capital Advisors first reported a position in WGS in Q4 2021 and held it in 1 quarter. The position peaked at $0 in Q4 2021. 108 funds tracked by Wall St. Rank hold WGS as of Q1 2022.

Snowden Capital Advisors reported no remaining GeneDx Holdings position as of Q1 2022 after selling out during the quarter.
Snowden Capital Advisors sold 1 GeneDx Holdings share in Q1 2022.
Snowden Capital Advisors first reported a position in GeneDx Holdings in Q4 2021 and held it in 1 quarter.
Snowden Capital Advisors's GeneDx Holdings position peaked at $0 in Q4 2021.
108 funds tracked by Wall St. Rank held GeneDx Holdings as of Q1 2022.

Based on Snowden Capital Advisors's 13F filing for Q1 2022, filed 16 May 2022.